Abstract
Introduction:
Regulatory T-cells (Tregs) are characterized by the expression of Foxp3, a master regulator involved in the development and function of Tregs. Foxp3 expression is dependent on activity of the Treg specific demethylated site (TSDR), which contains a CREB binding site. We aimed to find out how Foxp3 specific CREB deletion affects Treg expression and function.
Methods:
Tregs from Foxp3creCREBfl/fl mice and wild type (CREBfl/fl) mice were analyzed by flow cytometry. Cytokine analysis was performed by flow cytometry, ELISA and RT-qPCR. Gene expression analysis was performed using Affymetrix HTA2 assays, ATAC-sequencing, and Methylation-assays. For functional relevance, a CD4 T cell mediated transfer colitis was performed.
Results and discussion:
Foxp3creCREBfl/fl mice showed increased frequencies of Tregs (CD25+/Foxp3+) in thymus, spleen and peripheral lymph nodes and in nonlymphoid organs including lung and colon, but decreased Foxp3 expression at the single cell level. Despite decreased Foxp3 expression, enhanced expression of the IL- 33 receptor (ST-2), IL-10, IL-13, and CREM was observed. CREB deficient Tregs were highly suppressive in vitro and prevented disease activity in a CD4 T cell mediated transfer colitis in an IL-10 dependent way. Mechanistically CREB fulfils dual roles in Tregs: (1) it promotes Foxp3 expression under Steady state conditions and (2) in cooperation with CREM, CREB restricts chromatin accessibility at the ST2 locus, thereby modulating IL-33 driven immune responses. This dual regulation balances FoxP3-dependent Treg stability with IL-10 mediated suppression of inflammation.

1 Introduction
Regulatory T cells (Tregs) marked by Foxp3 expression are important for immune balance. In the absence of Foxp3, mice (scurfy disease) () and humans (IPEX, polyglandular autoimmunopathy) develop severe autoimmune disease (). Foxp3 Tregs arise from two sources; thymus-derived Tregs (t-Tregs) develop in the thymus, while inducible Tregs (iTregs) are generated in the periphery from conventional CD4+ T cells upon TGF-β stimulation (). Both tTreg and iTreg generation largely depend on the presence of IL-2, which is not only required for homeostatic maintenance but also for the thymic development of Tregs (–).
ST-2, also known as IL1RL1, belongs to the Toll-like receptor/IL-1 receptor superfamily. ST-2, through its ligand IL-33, plays a pivotal role in MyD88/NFκB signaling. The interaction of ST-2 with its ligand IL-33 induces Foxp3 and GATA3 expression in Tregs at mucosal sites (). ST-2 mainly exists in two isoforms: soluble ST-2 (sST-2) and membrane-bound ST-2. sST-2 functions as a decoy receptor of IL-33 and inhibits NFκB signaling, while membrane-bound ST-2 promotes NFκB signaling (). Increased ST-2 levels have been observed in diseases such as inflammatory bowel disease (IBD), asthma, colon cancers, and graft versus host disease (). In many non-lymphoid tissues, Tregs show enriched expression of ST-2 and most of these are iTregs. The regulation of ST-2+Tregs is dependent on the transcription factor basic leucine zipper transcription factor ATF-like (BATF) (, ), while other factors have not yet been defined. BATF belongs to the cAMP-responsive element binding protein/activating transcription factor (CREB/ATF) family of transcription factors, can dimerize with Jun, and has been shown to compete with CREB for binding to CRE/AP1 sites.
Our understanding of the molecular mechanism of suppression is still limited. IL-10 plays an important role in suppressing CD4+ effector T-cell function. Additionally, IL-10 prevents activation of antigen-presenting cells (APCs), such as dendritic cells and macrophages, through the downregulation of costimulatory molecules and production of inflammatory cytokines within these cells (). Selective ablation of IL-10 in Foxp3+ Tregs revealed that IL-10 production by Tregs is essential for keeping the immune response in check at environmental interfaces such as the colon and lungs (). IL-10 also acts in an autocrine manner by maintaining FoxP3 expression and the suppressive capacity of Tregs (, ). Interestingly, IL-10 is responsive to cAMP stimulation, at least in THP1 cells and macrophages, and the IL-10 promoter contains four putative cAMP response element sites (CRE, TGACGTCA), which are conserved between humans and mice (). Following TLR activation, pCREB (phosphorylated CREB) is recruited to the IL-10 promoter and enhances IL-10 transcription in macrophages ().
Previous data from Wang et al. () suggested that CREB negatively regulated the survival of iTregs and is particularly important in the generation of CD4+Th17 cells. Using CD4CRE CREBfl/fl mice, they showed that these cells prevented colitis in a Rag2-/- model; however, their model had the disadvantage that the CD4 cells of these mice expressed lower amounts of IL-2, which could have hampered iTreg induction. Our analysis now expands upon their findings and determines an important role for CREB in the generation of ST2+Tregs. Using Foxp3CRECREBfl/fl mice, we herein confirm the colitis phenotype but can show that i) CREB deficiency in Tregs induces expression of ST2+Tregs, ii) the phenotype that prevents colitis in Rag2-/- mice is primarily dependent on abundance of IL-10, and iii) this phenotype can be reversed by knockout of CREM, which lowers the expression of ST2.
2 Materials and methods
2.1 Mouse strains
Experiments were performed with age-matched CREBfl/fl, VAVcreCREBfl/fl, and Foxp3creCREBfl/fl mice (all C57BL/6). Foxp3creCREBfl/fl mice were generated by crossing CREB-flox mice () with C57BL/6 Foxp3-IRES Cre mice (provided by T. Bopp, University of Mainz, Germany). Foxp3cre-CREBfl/fl mice were used as controls (denoted as CREBfl/fl). Foxp3CreROSARFP mice were provided by T. Bopp University of Mainz and crossed with our CREBfl/fl mice. Rag2-/- (C57BL/6) mice were provided by A. Schippers (Uniklinik RWTH Aachen, Germany). All the mice were bred in our animal facility and kept under standardized conditions.
2.2 Transfer colitis
To induce transfer colitis, Rag2-/- mice were adoptively transferred 2 x 106 CD4+ CD25- T cells. Animals were sacrificed as soon as a significant loss of weight was measurable. The spleen and mesenteric lymph nodes (mLNs) were harvested for further analysis. One part of the colon was fixed in formalin for histological scoring and the other part was fixed in RNAlater (Qiagen, Germany) for subsequent mRNA analysis. For soluble ST2 (sST2) treatment, the mice received 100 µg mouse sST2 (produced by the VIB Protein Core facility, Belgium, and provided by R. Beyaert, VIB-UGent Center for Inflammation Research, Belgium), three times/week by intraperitoneal means (i.p). The control group received PBS i.p. For IL-10R treatment, the mice received 500 µg anti-IL-10R antibody (1B1mAB) (kindly provided by Prof. Edgar Schmitt, University of Mainz, Germany) or IgG control AK (Rat IgG kappa) i.p. once a week during the first 3 weeks.
2.3 Histological scoring
Initially, 4 µm paraffin sections from the fixed colon were cut serially, mounted onto glass slides, and deparaffinized. The colon sections were stained with hematoxylin and eosin by the Core Facility (IZKF) of the RWTH Aachen University. Blinded histological scoring was performed using a standard microscope, based on the JLS method as described previously (, ). Each colon section was scored for the four general criteria: severity, degree of hyperplasia, degree of ulceration, if present, and percentage of area involved. A subjective range of 1–3 (1 = mild, 2 = moderate, 3 = severe) was used for the first three categories. Severity: Focally small or widely separated multifocal areas of inflammation limited to the lamina propria were graded as mild lesions (1). Multifocal or locally extensive areas of inflammation extending to the submucosa were graded as moderate lesions (2). If the inflammation extended to all layers of the intestinal wall or the entire intestinal epithelium was destroyed, lesions were graded as severe (3). Hyperplasia: Mild hyperplasia consisted of morphologically normal lining epithelium that was at least twice as thick (length of crypts) as adjacent or control mucosa. Moderate hyperplasia was characterized by the lining epithelium being two or three times the normal thickness, cells were hyperchromatic, numbers of goblet cells were decreased, and scattered individual crypts developed an arborizing pattern. Severe hyperplastic regions exhibited a markedly thickened epithelium (four or more times normal thickness), marked hyperchromasia of cells, few to no goblet cells, a high mitotic index of cells within the crypts, and numerous crypts with an arborizing pattern. Ulceration was graded as: 0 = no ulcer, 1 = 1–2 ulcers (involving up to a total of 20 crypts), 2 = 1–4 ulcers (involving a total of 20–40 crypts), and 3 = any ulcers exceeding the former in size. A 10% scale was used to estimate the area involved in the inflammatory process. 0 = 0%, 1 = 10%–30%, 2 = 40%–70%, 3 = >70%.
2.4 Cell isolation
Single cell suspensions were isolated from spleens and lymph nodes (LNs) [peripheral lymph nodes (pLNs) and mLNs] using cell strainers and erythrocytes were lysed with lysis buffer. To obtain immune cells from the lungs, tissue was excised into small pieces and digested with 0.1% collagenase in DPBS for 1hr. The digested fraction was passed through a 40μm nylon strainer and rinsed with DPBS. The flow through was centrifuged and the cell pellet was lysed using RBC lysis buffer. The cell pellet was used for the flow cytometric analysis. Colons were retrieved from the mice and rinsed with a cannula with PBS+0.5%BSA. Afterwards, the colons were excised into small pieces and placed in a digestive medium containing RPMI (10mL), collagenase V (0.85mg/mL), collagenase D (1.25mg/mL), dispase (1mg/mL) and DNase (30μg/mL) and incubated for 45 minutes at 37°C with gentle shaking. The digested fraction was passed through a 40 μm nylon strainer and the flow-through was collected and centrifuged to obtain a pellet. Percoll gradient centrifugation was performed by using 35% Percoll. The cell pellet obtained was lysed using RBC lysis buffer and was used for further analysis. The livers were retrieved from the mice. The gall bladders were removed and the livers were excised into small pieces and placed in a digestive medium containing RPMI without FCS (3mL), 1.25mg/mL collagenase D, and 30μg/mL DNase. The fraction was incubated for 45 minutes and digestion was stopped by adding PBS+0.5% BSA+2mM EDTA and homogenized using a syringe. The digested fraction was passed through a 100μm nylon strainer and the flow-through was centrifuged. The pellet obtained was used for the Percoll gradient centrifugation using 35% Percoll. The cell pellet obtained after the Percoll gradient centrifugation was lysed using RBC lysis buffer and was used for the flow cytometric analysis.
2.5 Suppression Assay
CD4 T-cells (Teffector cells) were isolated from the spleens of wild-type mice. The cells were labeled with eFluor 660 proliferation dye from Thermo Fischer according to the manufacturer’s instructions. After the labeling, the cells were stimulated with plate-coated anti-CD3 (10µg/mL, eBioscience, Germany) and soluble anti-CD28 (1µg/mL) (eBioscience) in the presence of CD4+CD25+ cells from either wild-type or Foxp3creCREBfl/fl mice in different ratios (1:0, 1:0.5, 1:0.75, and 1:1) for 3 days. After 3 days of stimulation, the cells were analyzed using flow cytometric analysis.
2.6 T cell differentiation assays
Magnetic Activated Cell Sorting (MACS)-isolated CD4+CD25- T cells (2x106 per mL) were incubated with plate-coated anti-CD3 (10µg/mL, eBioscience, Germany) and soluble anti-CD28 (1µg/mL) (eBioscience, Germany). TH0 cells were left without exogenous cytokines, and 5 ng/mL TGF-β was added to induce Treg differentiation.
2.7 Flow cytometry
For surface staining, single cell suspensions were stained with anti-CD4, anti-CD3, anti-CD8, anti-B220, anti-CD25, CD45, anti-GL-7, anti-ICOS, anti-ST2, anti-Nrp1, and anti-PD-1 (all from eBioscience, Germany). For intracellular staining of CREB, Foxp3, CTLA-4, Helios, GATA3, T-bet, and RORγt, cells were fixed and permeabilized with a FOXP3 staining buffer set (Thermo Fischer, eBioscience, Germany) following the manufacturer’s instructions and stained with respective antibodies (eBioscience, Germany) for 30 min. Intracellular cytokines were stained with anti-IFN-γ-Alexa 647 (eBioscience, Germany) and anti-IL-17-Alexa 488 (BD, USA), and IL-10-APC (eBioscience, Germany) after PMA (30nM) and Ionomycin (1.5µM) (both Sigma-Aldrich, USA) re-stimulation in the presence of GolgiPlug/GolgiStop (BD Biosciences, USA). A daily calibrated FACS-Canto II flow cytometer (Becton Dickinson, MountainView, CA, USA) was used to perform the phenotypic analysis. Lymphocytes were gated by forward (FSC), side scatter (SSC), and CD3, CD4, and B220 expression. A figure exemplifying the gating strategies is provided in the Supplementary Materials (Supplementary Figure 6). For data analysis FCS-Express 4.0 Research Edition (DeNovo software Glendale, CA, USA) and FlowJo version 10 were used.
2.8 Luciferase assay
RLM cells carrying a stable pGL3-TSDR-FoxPro luciferase plasmid were kindly provided by Jochen Huehn (HZI Braunschweig, Germany). Cells were transfected with the pcDNA-CREB plasmid or pcDNA. Cells were left to rest overnight before luciferase activity was measured by using the Dual-Glo Luciferase Assay System (Promega, USA).
2.9 RNA isolation and real-time PCR
Total RNA from isolated T cells and colon tissue was isolated using the RNeasy Mini Kit (Qiagen, Germany). cDNA was then generated from 200 ng total RNA using the RevertAid H Minus First Strand cDNA Synthesis Kit (Thermo Fisher Scientific, USA) according to the manufacturer´s instructions. RT-PCR was performed using the SYBR Green PCR kit (Eurogentec, Germany) and data were acquired with the ABI Prism 7300 RT-PCR system (Applied Biosystems/Life Technologies, Germany). Each measurement was set up in duplicate. After normalization to the endogenous reference control gene ß-actin for mice, the relative expression was calculated.
2.10 RNA extraction and microarray for gene expression analysis
CD4+CD25+Nrp1+ Tregs were sorted by FACS. Genome-wide transcriptome analyses of FoxpcreCREBfl/fl and CREBfl/fl Tregs were performed in independent triplicate using Gene Chip® Mouse Gene 2.0 arrays (Affymetrix, Santa Clara, CA, USA). Total RNA extraction was carried out using the RNeasy Micro Kit (Qiagen, Germany) according to the manufacturer’s protocol and then quantified (Nanodrop). RNA quality was assessed using the RNA 6000 Nano Assay with the 2100 Bioanalyzer (Agilent, Santa Clara, CA, USA). Samples for the Gene 2.0 arrays were prepared and hybridized to the arrays according to the Affymetrix WT Plus Kit manual. Briefly, for each sample, 100 ng of total RNA was reverse-transcribed into cDNA using a random hexamer oligonucleotide tagged with a T7 promoter sequence. After second-strand synthesis, double-strand cDNA was used as a template for amplification with T7 RNA polymerase to obtain antisense cRNA. Random hexamers and dNTPs spiked out with dUTP were then used to reverse-transcribe the cRNA into single-stranded sense-strand cDNA. The cDNA was then fragmented with uracil DNA glycosylase and apurinic/apyrimidic endonuclease 1. The fragment size was checked using the 2100 Bioanalyzer and ranged from 50 to 200 bp. Fragmented sense cDNA was biotin-end-labeled with TdT and the probes were hybridized to the Gene 2.0 arrays at 45°C for 16h with 60 rpms. Hybridized arrays were washed and stained on a Fluidics Station 450 (program: FS450 0002) and scanned on a GeneChip® Scanner 3000 7G (both Affymetrix). Raw image data were analyzed with Affymetrix® Expression Console™ Software (Affymetrix, USA), and gene expression intensities were normalized and summarized with a robust multiarray average algorithm (). Transcripts that were expressed differently more than 1.5-fold with a raw p-value lower than 0.05 between the sample groups were categorized as regulated. A enrichment analysis for Wiki pathways was performed using WebGestalt (). For the enrichment analysis only, genes that changed at least 1.5-fold with a p-value lower than 0.05 between Foxp3creCREBfl/fl and CREBfl/fl samples were taken into consideration.
2.11 TSDR methylation analysis
For all the methylation analyses, cells from male mice were used. Genomic DNA was prepared from FACS-sorted Tconv cells (CD4+CD25-) and Treg cells (CD4+CD25+Nrp1+) from CREBfl/fl and Foxp3creCREBfl/fl mice and subsequently converted by bisulfite according to the manufacturer’s instructions (DNeasy Blood & Tissue Kit, Qiagen; EZ DNA Methylation-Lightning Kit, Zymo Research, USA). Pyrosequencing of the Treg cell-specific demethylated region (TSDR) (chromosome position X:7583950-7584149, genome assembly GRCm38.p6) was performed as described previously ().
2.12 Transposase-accessible chromatin assay using sequencing
Omni-transposase-accessible chromatin assay using sequencing (ATAC-seq) was performed according to (, ) with minor modifications. Prior to transposition, dead cells were removed by centrifugation (800 rpm, 4 min, 4°C). The transposition reaction was conducted with 7.5 μL Tagment DNA Enzyme 1 (TDE1) for 60 min at 37°C. Pre-amplification was conducted with NEBNext Ultra II Q5 Master Mix and Nextera PCR Primers (5 cycles). Quantitative PCR amplification was conducted with NEBNext Ultra II Q5 Master Mix, Nextera PCR Primer, and SYBR Gold to determine the number of additional cycles. PCR amplification of additional cycles was the same as for pre-amplification. PCR fragments were purified with Qiagen MinElute PCR Purification Kit and library concentration and quality were determined using an Agilent High Sensitive DNA Kit and TapeStation, respectively. ATACseq libraries were sequenced on the Illumina NextSeq 500 Platform with 75 bps paired-end reads in duplicate. ATAC-seq libraries were trimmed with Trim Galore (parameters -q 30 –paired –trim1) and aligned to the mouse genome (mm9) using Bowtie2 () (parameters -X2000 –no-mixed –no-discordant). Duplicate fragments were removed, and reads were filtered for alignment quality of >Q30 using samtools (). Next, we used MAC2 () to perform peak calling (parameters: nomodel, nolambda, keep-dup auto, call-summits). Transcription factor footprinting and differential activity was performed using HINT-ATAC as described in Li et al. ().
2.13 ELISA
Total IgG and IgE were measured from sera using the Ready-Set-Go ELISA system (affymetrix: eBioscience, USA). IL-10 was determined in cell supernatants using mouse IL-10 ELISA Ready-SET-GO! (2nd Generation) (Thermo Fisher Scientific, USA), according to the manufacturer’s instructions.
2.14 Statistical analysis
All data are presented as mean ± standard error (SEM). Data were tested for normality using the Shapiro–Wilk normality test. Differences between two groups were evaluated using two-tailed unpaired or paired (if indicated) Student’s t-tests. A two-tailed Mann–Whitney test was used if data were not normally distributed. One-way ANOVA was performed if there are more than two groups. Measurements were taken from distinct samples. All statistical analysis and subsequent graphics generation were performed using GraphPad Prism versions 7.0 and 8.0 (GraphPad Software, USA). A p-value <0.05 was statistically significant.
2.15 Study approval
The animal study was approved by the regional government authorities and animal procedures were performed according to German legislation for animal protection. Permission for the projects was granted by the Regierungspräsident/LANUV Nordrhein-Westfalen (81-02.04. 2017.A393).
2.16 Data availability
The ATAC-Seq and microarray raw datasets have been deposited in GEO under the accession codes GSE157693 and GSE157933. All data that support the findings of this study are available within the article and the Supplementary Material. All other data, including raw data used in each figure, will be provided upon reasonable request to the corresponding author.
3 Results
3.1 CREB enhances Treg numbers but downregulates Foxp3 expression in Tregs
CREB is a transcriptional activator and has been found to critically stabilize Foxp3 expression (). It is therefore widely accepted that CREB promotes FoxP3 expression in Tregs (32–34). To verify this hypothesis in vivo, we generated mice with a Foxp3-specific knockout of CREB (Foxp3creCREBfl/fl). To our surprise, these mice showed enhanced numbers of CD25+/Foxp3+ positive Tregs in the thymus (Figures 1A, D), spleen (Figures 1B, D), and pLN (Figures 1C, D). Splenic Tregs showed no altered expression of Nrp1, PD-1, CTLA4, and ICOS (Supplementary Figures 1A, B). There was also no convincing different expression of Th lineage transcription factors GATA3 and RORyT and T-bet in CD4+Foxp3+ cells within different organs (Supplementary Figures 2A–E). However, Foxp3creCREBfl/fl mice displayed lower Foxp3 expression in Tregs on the single cell level (Figures 1E, F), which can be explained by the fact that CREB directly activates the TSDR () (Figure 1G). To verify Cre expression in the Foxp3-Cre mice, we crossed Foxp3creCREBfl/fl mice with Cre-inducible reporter mice (ROSARFP) and examined reporter gene expression in lymphocytes. RFP expression was confined to CD4+CD25+ cells, which is important for excluding cell extrinsic side-effects (Figures 1H, I).
Figure 1
We further used Foxp3creCREBfl/fl ROSARFP mice to assess the percentages of Tregs in non-lymphoid organs. While we did not observe differences in liver tissue, we found a particularly marked upregulation of Treg percentages within the lungs and colons of Foxp3creCREBfl/fl ROSARFP mice compared to Foxp3creROSARFP mice (Figures 1J–L) and enhanced absolute numbers of Tregs in the colons of Foxp3creCREBfl/fl ROSARFP (Supplementary Figure 7B). This prompted us to analyze whether CREB expression in Tregs differs in different tissues. We could not find an association between high tissue-dependent CREB expression and the effects of CREB deficiency on Treg percentages; however, we found a high expression of CREB in murine colonic Tregs (Supplementary Figure 8).
3.2 CREB-deficient Tregs are suppressive in vitro
To test whether lower Foxp3 expression affects the suppressive capacity of CREB-deficient Tregs, we co-cultured CREBfl/fl Tregs and Foxp3creCREBfl/fl Tregs with anti-CD3 and anti-CD28 stimulated WT CD4+ cells. Surprisingly, Foxp3creCREBfl/fl Tregs revealed an increased capacity to reduce CD4+ T cell proliferation (Figures 2A, B). These data suggest that deletion of CREB, despite reducing Foxp3 expression per cell, enhances the function of Tregs. In addition, the expression of Helios was enhanced (Figure 2C) and bisulfite sequencing revealed a demethylated TSDR (Figure 2D), which suggests a stable and suppressive phenotype (35). In conclusion, despite the reduction of Foxp3 levels per cell, CREB deficiency leads to stable and functional Tregsin vitro.
Figure 2
3.3 CREB-deficient Tregs reveal gene expression signature with enhanced expression of IL-10, IL-4, IL-13, and ST2
To understand why CREB-deficient Tregs are suppressive despite reduced Foxp3 expression, we performed a whole transcriptome analysis (Affymetrix HTA2 arrays) of flow-sorted (CD4+CD25+Nrp-1+) Foxp3creCREBfl/fl and CREBfl/fl Tregs (Supplementary Figure 3A) and appropriate wild-type mice because, at the time of this analysis, the Foxp3CRECREBfl/fl ROSARFP mice were not yet available. Using a fold-change of 1.5 and a p-value of less than 0.05, we found 111 downregulated and 122 upregulated genes in the Foxp3creCREBfl/fl compared to the CREBfl/fl Tregs, and among them, IL-10 and IL-13 were the two most differentially regulated in the Foxp3creCREBfl/fl Tregs (Figure 3A). KEGG pathway analysis revealed an enrichment of differentially regulated genes in pathways that are associated with Th2 cytokines, such as asthma, Th2 and Th2 cell differentiation, and cytokine-cytokine receptor interaction pathways (Figure 3B). Higher Il13 and Il10 mRNA expression in Foxp3creCREBfl/fl Tregs could be further confirmed by RT-qPCR (Figures 3C, D). CD4+CD25+Foxp3+ cells also showed enhanced IL-10 protein levels after 3 days of CD3/CD28 stimulation, as assessed by flow cytometry (Figures 3E, F). In vitro Treg differentiation with TGF-β revealed a reduced capacity of Foxp3creCREBfl/fl T cells to differentiate towards Foxp3+ cells, while IL-10 expressing cells within Foxp3+ cells were enhanced (Figure 3G). Furthermore, IL-10 cytokine expression of TGF-β−stimulated Foxp3creCREBfl/fl T cells measured by ELISA was enhanced, as was Il13, Il5, and Il10 mRNA expression, which suggests that CREB deficiency in Tregs induces a Th2-biased phenotype (Figures 3H-L). Beyond cytokines, Il1r1 (ST2) showed enhanced expression on the microarray. ST2, the receptor of IL-33, is preferentially expressed on colonic Tregs, where it promotes Treg function and adaptation to the inflammatory environment. It provides a necessary signal for Treg-cell accumulation and maintenance in inflamed tissues, and it was shown to regulate IL-10-expressing Tregs in the gut (). In addition, IL-33 has been identified as a major interleukin in asthma pathology (36). ST2 was highly expressed in the Foxp3creCREBfl/fl Tregs, which was confirmed by flow cytometry (Figures 3M, N). Moreover, the whole transcriptome analysis also revealed an upregulated expression of CREM in Foxp3creCREBfl/fl Tregs and qRT-PCR also showed tendentially enhanced CREM expression in Foxp3creCREBfl/fl Tregs (Figure 3O). In conclusion, these data suggest that CREB deletion induces ST2+ Tregs. This finding led us to investigate the protein expression of ST2 within different organs in Foxp3creROSARFP and Foxp3creCREBfl/flROSARFP mice. ST2 expression was clearly enhanced in Tregs in the thymus, spleens, mesenteric lymph nodes, lungs, and colons of these mice (Figures 3P–T).
Figure 3
3.4 Foxp3creCREBfl/fl T cells dampen inflammation in experimental colitis
Since ST2+Tregs also play a protective role in intestinal mucosal inflammation (), we performed a transfer of Foxp3creCREBfl/fl T cells (CD4+CD25-) or appropriate CREBfl/fl T cells (CD4+CD25-) into lymphopenic Rag2-/- mice. This usually results in the development of colitis within 5 weeks. Strikingly, the transfer of Foxp3creCREBfl/fl T cells did not result in the expected weight loss (Figure 4A) and the recipient mice displayed decreased intestinal inflammation (Figures 4B, C). Furthermore, there was a significant decrease of Il6, Tnfa, Il17a, and Ifng, along with a non-significant trend towards decreased Il1b in the gut (Figure 4D) and reduced IFN-γ production. There was also a trend towards reduced IL-17A in CD4+ T cells in the mLNs (Supplementary Figure S4E–G). Limitations include the absence of IL-6 and TNFα protein data due to the limited availability of the tissue. The experiment was repeated with CD4+CD25- T cells from Foxp3creROSARFP and Foxp3creCREBfl/fl ROSARFP mice into Rag2-/- mice and with CD4+CD25- cells from CREBfl/fl and VAVcreCREBfl/fl mice into Rag2-/- mice, with the same results. The transfer of CD4+CD25- T cells from Foxp3creCREBfl/fl ROSARFP mice (Figures 5A–G) and from VAVcreCREBfl/fl prevented the development of colitis (Supplementary Figure 11) and resulted in enhanced accumulation of RFP+ Tregs in different organs (Figures 5A–G). Interestingly, RFP+ Tregs also accumulated in the liver, while we did not find a difference in the RFP expression in the Foxp3creCREBfl/fl ROSARFP mice under steady state conditions.
Figure 4
Figure 5
3.5 Blockade of IL-10 but not of ST2 signaling reverses the protective effects of Foxp3creCREBfl/fl T cells in experimental colitis
ST2+ Tregs are protective in intestinal inflammation (), and,in addition, they are Th2 biased and release IL-10 (37). To decipher whether Foxp3creCREBfl/fl T cells prevent colitis through IL-10 production and/or ST2 expression, we performed an adoptive transfer colitis experiment with anti-IL10R antibodies or recombinant soluble ST2 (sST2). sST2 acts as a decoy for IL-33 and inhibits its biological activity (38). The blockade of IL-10 signaling induced colitis in the formerly resistant Foxp3creCREBfl/fl T cell-recipient mice (Figures 6A–C), while the ST2 blockade had no effect on disease progression (Supplementary Figure 4).
Figure 6
3.6 Genome-wide chromatin accessibility of WT and CREB-deficient Tregs
To analyze whether CREB deletion alters chromatin accessibility at different promoters and enhancers, we performed ATAC-seq in CREBfl/fl and Foxp3creCREBfl/fl Tregs. We observed a decrease in open chromatin around CREB and CREM motifs in the Foxp3creCREBfl/fl mice, which indicates loss of binding activity of these transcription factors in these cells (Figure 7A). The Il1rl1 (ST2) region showed significant differences in open chromatin around the original and an alternative promoter in Tregs from the Foxp3creCREBfl/fl mice, while canonical CRE motifs, which are 8-base pair palindromic sequences (5′-TGACGTCA-3′), could not be identified (Figure 7B). In addition, the IL-10 enhancer region showed clear differences between the two mouse strains. Within this region, binding sites for Nrf1 were identified, which is a CREB-dependent transcription factor (39). Moreover, we found a change in open chromatin of an alternate promoter of CREM (Figure 7C). CREM has been identified as one of the most regulated genes in ST-2 positive colonic Tregs of healthy mice (40). To prove whether CREM is involved in the regulation of ST2, we generated Foxp3creCREBfl/flCREM-/- mice. In vitro differentiation towards Foxp3+ cells was not significantly diminished in Foxp3creCREBfl/flCREM-/- mice (Figure 7D). Furthermore, deletion of CREM normalized Foxp3 expression per cell in CREB-deficient Tregs at least to some extent (Figure 7E) but reversed the expression of ST2 (Figure 7F). Taken together, our data suggest that the interaction of CREB and CREM determines the expression of Foxp3 and ST2 and the induction of CREM in CREB-deficient Tregs contributes to reduced Foxp3 expression. To prove the effect in vivo, we performed a transfer of Foxp3creCREBfl/flCREM-/- T cells (CD4+CD25-) or appropriate wild-type T cells (CD4+CD25-) into lymphopenic Rag2-/- mice. The additional genetic deletion of CREM reversed the effect of the CREB deletion and resulted in enhanced colitis severity, measured by JLS (The Jackson Laboratory Scoring) score in the transferred mice (Figure 7G).
Figure 7
4 Discussion
In this study, we provide evidence that CREB cells intrinsically regulate Foxp3 expression in Tregs and thereby play a critical role in Treg cell-mediated immune homeostasis. In detail, CREB deficient Tregs showed a reduced expression of Foxp3 per cell but enhanced expression of ST2, IL-10, and IL-13. Enhanced IL-10 expression of CREB-deficient Tregs prevents T cell-mediated colitis. Enhanced IL-10 expression is also a hallmark of ST2+ Tregs. ST2 is expressed on colonic Tregs and enhances local intestinal Treg cell responses (). We identified particularly enhanced expression of Tregs in the colons and lungs of Foxp3creCREBfl/fl mice, which also includes upregulation of ST2 expression and may contribute to the unexpectedly protective role of CREB deletion in Tregs in type I immune responses. This protective role is in line with Wang et al. () who demonstrated an important role for CREB in regulating the balance between Th17 cells and Tregs. They showed that mice bearing a deletion of CREB in all CD4+ T cells prevented T cell-mediated transfer colitis comparable to our model. Moreover, these mice were also resistant in an EAE model. This protective effect in EAE was surprisingly lost when CREB was specifically deleted in Tregs. Nevertheless, except in the EAE model, Wang et al. did not analyze the Foxp3-specific CREB-deleted mice in further detail.
We hypothesize that, in particular, the enhanced IL-10 secretion prevented colitis in Rag-/- mice that received Foxp3creCREBfl/fl CD4+ T cells. IL-10 is an important regulator of intestinal homeostasis, as IL-10 and IL-10R deficient mice spontaneously develop intestinal inflammation (41, 42) and blocking IL-10 signaling induced colitis in Foxp3creCREBfl/fl T cell recipients that were previously resistant. It has been shown before that CREB induces IL-10 transcription in macrophages. Our data, thus, were highly unexpected and do not support these findings but may instead argue for cell-dependent mechanisms that regulate IL-10 expression. Our ATAC-seq data however do not show a direct effect of CREB expression on chromatin accessibility within the IL-10 enhancer and promoter region, thus we currently cannot mechanistically explain these findings.
We also found enhanced percentages of Tregs within the thymus, spleens, and pLNs but reduced Foxp3 expression per cell within peripheral lymphoid organs. Wang et al. also suggest that compensation by related transcription factors such as CREM exist. Interestingly and corroborating that theory, we found a clear upregulation of CREM in CREB-deficient Tregs and additional deletion of CREM recuperates Foxp3 expression in CREB deficient Treg cells, while it downregulates ST2 expression. Strikingly, CREM expression, which was enhanced in Foxp3creCREBfl/fl Tregs, was found before as a highly regulated gene in ST2-positive colon and skin Tregs (40). Delacher et al. characterized ST2+ tissue Tregs that are present in all non-lymphoid tissues, which were found to express killer cell lectin-like receptor subfamily G1 (KLRG1) and Th2-associated factors, including IL-10 (, ). These “tisTregsST-2” cells are programmed by BATF () in lymphoid organs and perform important tissue homeostasis and regenerative functions. Our data point to the fact that the expression of CREB and CREM also regulate these tisTregST2 in non-lymphoid tissues such as the colon, lungs, and liver. Spath et al. vigorously analyzed ST2 trajectories in mice and showed a high plasticity in ST2 expression and hierarchies in tissue-specific phenotypes (43). In addition, they found that ST2+ Tregs were highly proliferative and had a high migratory potential. This is in line with our findings that these cells can be found in the spleen, lung, liver, mLN, and the colon. They additionally found a high prevalence in skin and VAT, which was not analyzed in our setting. When comparing the transcriptional profiles with our analyses, we can confirm an upregulation of PTPN13 in our data (1.97-fold) and a regulation of Rab4a (-1.51-fold) between the CREB-deficient Tregs and wild-type Tregs, and the other factors that distinguished ST2+ from ST2- Tregs (Lyn, Gata3, Rln3, Klrg1, and Tbc1d4) were not different. Interestingly, in their analysis, ST2+ Tregs were enriched in more activated, differentiated Treg populations, such as ID2+ Tregs, and ID2 was upregulated in our analysis as well (1.7-fold) (43).
The limitations of our study are that we mainly mechanistically analyzed splenic Tregs, while ST2 is a hallmark of tissue Tregs, and further analysis will show how this affects local Tregs and tissue homeostasis. We observed an increase in regulatory T cell (Treg) frequencies and elevated ST2 expression in both lung and colon mucosal tissues. However, a limitation of our current study is that we did not perform comprehensive epigenetic and transcriptional profiling of the Tregs from these tissues, nor did we investigate the role of CREM, which has been suggested to compensate for ST2 expression from the splenic Tregs. These important aspects will be addressed in future studies to provide a deeper understanding of the mechanisms underlying Treg function and regulation in mucosal environments. Another issue is that it is not clear how CREB activation is regulated in Tregs. CREB has nine serine residues in the kinase inducible domain (KID) that can be phosphorylated and activated by different kinases and different phosphorylation patterns of CREB can exert opposite effects. Further research will therefore be necessary to identify therapeutic targets to directly influence CREB activity in Tregs. In conclusion, we provide evidence that CREB plays a pivotal role in Tregs. CREB is an important transcription factor to maintain Foxp3 expression, and the interaction of CREM and CREB is crucial for the expression of ST2 in Tregs. A lack of CREB enhances IL-10 expression and thereby prevents Th1-mediated diseases.
Statements
Data availability statement
The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: https://www.ncbi.nlm.nih.gov/geo/, GSE157693 https://www.ncbi.nlm.nih.gov/geo/, GSE157933.
Ethics statement
The animal study was approved by Regierungspräsident/LANUV Nordrhein-Westfalen. The study was conducted in accordance with the local legislation and institutional requirements.
Author contributions
SHS: Formal analysis, Visualization, Writing – original draft, Validation, Writing – review & editing, Methodology, Investigation. JHr: Writing – review & editing, Investigation. SS: Investigation, Writing – review & editing. TL: Writing – review & editing, Investigation. TG: Writing – review & editing, Investigation. TC: Writing – review & editing, Investigation. MS: Writing – review & editing, Investigation. MK: Writing – review & editing, Conceptualization. EV: Writing – review & editing, Investigation. SB: Investigation, Writing – review & editing. CN: Writing – review & editing, Investigation. IC: Formal analysis, Writing – review & editing. ZL: Writing – review & editing, Formal Analysis. LG: Formal analysis, Writing – review & editing. BD: Formal analysis, Writing – review & editing. AS: Writing – review & editing, Resources. SF: Writing – review & editing, Formal analysis, Investigation. JHu: Writing – review & editing, Conceptualization, Formal analysis. ES: Writing – review & editing, Resources. TB: Resources, Writing – review & editing, Conceptualization. HW: Resources, Writing – review & editing. RW: Resources, Writing – review & editing. RB: Resources, Writing – review & editing. BL: Writing – review & editing, Resources. MZ: Writing – review & editing, Conceptualization, Formal analysis. NW: Writing – review & editing. KO: Supervision, Project administration, Methodology, Investigation, Conceptualization, Data curation, Formal analysis, Writing – review & editing, Visualization. KT: Funding acquisition, Project administration, Visualization, Data curation, Supervision, Writing – review & editing, Conceptualization, Methodology.
Funding
The author(s) declare that financial support was received for the research and/or publication of this article. DFG grant TE339/20-1 to KT. KT and KO got support from the Interdisciplinary Centre for Clinical Research within the Faculty of Medicine at the RWTH Aachen University (IZKF grant Project number – PTD 1-7). JH and TB were supported by the DFG grant SFB/TRR355/1 (Project number:490846870).
Acknowledgments
The authors acknowledge the IZKF Flow Cytometry Facility for the use of a cell sorter (DFG grant project ID 439895892) and the genomics facility for their service.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Generative AI statement
The author(s) declare that no Generative AI was used in the creation of this manuscript.
Correction note
This article has been corrected with minor changes. These changes do not impact the scientific content of the article.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fimmu.2025.1601008/full#supplementary-material
References
1
WildinRSRamsdellFPeakeJFaravelliFCasanovaJLBuistNet al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet. (2001) 27:18–20. doi: 10.1038/83707
2
BennettCLChristieJRamsdellFBrunkowMEFergusonPJWhitesellLet al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet. (2001) 27:20–1. doi: 10.1038/83713
3
ZhouXBailey-BucktroutSLJekerLTPenarandaCMartínez-LlordellaMAshbyMet al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol. (2009) 10:1000–7. doi: 10.1038/ni.1774
4
SetoguchiRHoriSTakahashiTSakaguchiS. Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med. (2005) 201:723–35. doi: 10.1084/jem.20041982
5
ZornENelsonEAMohseniMPorcherayFKimHLitsaDet al. IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood. (2006) 108:1571–9. doi: 10.1182/blood-2006-02-004747
6
LiaoWLinJXLeonardWJ. IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation. Curr Opin Immunol. (2011) 23:598–604. doi: 10.1016/j.coi.2011.08.003
7
OhlKTenbrockK. Regulatory T cells in systemic lupus erythematosus. Eur J Immunol. (2015) 45:344–55. doi: 10.1002/eji.201344280
8
SchieringCKrausgruberTChomkaAFröhlichAAdelmannKWohlfertEAet al. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature. (2014) 513:564–8. doi: 10.1038/nature13577
9
KakkarRLeeR. The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov. (2008) 7:827–40. doi: 10.1038/nrd2660
10
GriesenauerBPaczesnyS. The ST2/IL-33 axis in immune cells during inflammatory diseases. Front Immunol. (2017) 24:475. doi: 10.3389/fimmu.2017.00475
11
DelacherMImbuschCDWeichenhanDBreilingAHotz-WagenblattATrägerUet al. Genome-wide DNA-methylation landscape defines specialization of regulatory T cells in tissues. Nat Immunol. (2017) 18:1160–72. doi: 10.1038/ni.3799
12
DelacherMImbuschCDHotz-WagenblattAMallmJPBauerKSimonMet al. Precursors for nonlymphoid-tissue treg cells reside in secondary lymphoid organs and are programmed by the transcription factor BATF. Immunity. (2020) 52:295–312.e211. doi: 10.1016/j.immuni.2019.12.002
13
OkamotoAFujioKOkamuraTYamamotoK. Regulatory T-cell-associated cytokines in systemic lupus erythematosus. J BioMed Biotechnol. (2011) 2011:463412. doi: 10.1155/2011/463412
14
RubtsovYPRasmussenJPChiEYFontenotJCastelliLYeXet al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity. (2008) 28:546–58. doi: 10.1016/j.immuni.2008.02.017
15
MuraiMTurovskayaOKimGMadanRKarpCLCheroutreHet al. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat Immunol. (2009) 10:1178–84. doi: 10.1038/ni.1791
16
UnutmazDPulendranB. The gut feeling of Treg cells: IL-10 is the silver lining during colitis. Nat Immunol. (2009) 10:1141–3. doi: 10.1038/ni1109-1141
17
BrennerSPröschSSchenke-LaylandKRieseUGausmannUPlatzerC. cAMP-induced Interleukin-10 promoter activation depends on CCAAT/enhancer-binding protein expression and monocytic differentiation. J Biol Chem. (2003) 278:5597–604. doi: 10.1074/jbc.M207448200
18
SaninDEPrendergastCTMountfordAP. IL-10 production in macrophages is regulated by a TLR-driven CREB-mediated mechanism that is linked to genes involved in cell metabolism. J Immunol. (2015) 195:1218–32. doi: 10.4049/jimmunol.1500146
19
WangXNiLChangDLuHJiangYKimBSet al. Cyclic AMP-responsive element-binding protein (CREB) is critical in autoimmunity by promoting th17 but inhibiting treg cell differentiation. EBioMedicine. (2017) 25:165–74. doi: 10.1016/j.ebiom.2017.10.010
20
OkawaHMotohashiHKobayashiAAburataniHKenslerTWYamamotoM. Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity. Biochem Biophys Res Commun. (2006) 339:79–88. doi: 10.1016/j.bbrc.2005.10.185
21
BleichAMählerMMostCLeiterEHLiebler-TenorioEElsonCOet al. Refined histopathologic scoring system improves power to detect colitis QTL in mice. Mamm Genome. (2004) 15:865–71. doi: 10.1007/s00335-004-2392-2
22
PilsMCBleichAPrinzIFasnachtNBollati-FogolinMSchippersAet al. Commensal gut flora reduces susceptibility to experimentally induced colitis via T-cell-derived interleukin-10. Inflammation Bowel Dis. (2011) 17:2038–46. doi: 10.1002/ibd.21587
23
IrizarryRAHobbsBCollinFBeazer-BarclayYDAntonellisKJScherfUet al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. (2003) 4:249–64. doi: 10.1093/biostatistics/4.2.249
24
WangJDuncanDShiZZhangB. WEB-based GEne seT anaLysis toolkit (WebGestalt): update 2013. Nucleic Acids Res. (2013) 41:W77–83. doi: 10.1093/nar/gkt439
25
GargGMuschaweckhAMorenoHVasanthakumarAFloessSLepennetierGet al. Blimp1 prevents methylation of foxp3 and loss of regulatory T cell identity at sites of inflammation. Cell Rep. (2019) 26:1854–1868 e1855. doi: 10.1016/j.celrep.2019.01.070
26
CorcesMRTrevinoAEHamiltonEGGreensidePGSinnott-ArmstrongNAVesunaSet al. An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues. Nat Methods. (2017) 14:959–62. doi: 10.1038/nmeth.4396
27
LiZSchulzMHLookTBegemannMZenkeMCostaIG. Identification of transcription factor binding sites using ATAC-seq. Genome Biol. (2019) 20:45. doi: 10.1186/s13059-019-1642-2
28
LangmeadBSalzbergSL. Fast gapped-read alignment with Bowtie 2. Nat Methods. (2012) 9:357–9. doi: 10.1038/nmeth.1923
29
LiHHandsakerBWysokerAFennellTRuanJHomerNet al. The sequence alignment/map format and SAMtools. Bioinformatics. (2009) 25:2078–9. doi: 10.1093/bioinformatics/btp352
30
ZhangYLiuTMeyerCAEeckhouteJJohnsonDSBernsteinBEet al. Model-based analysis of chIP-seq (MACS). Genome Biol. (2008) 9:R137. doi: 10.1186/gb-2008-9-9-r137
31
KimHPLeonardWJ. CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation. J Exp Med. (2007) 204:1543–51. doi: 10.1084/jem.20070109
32
RuanQKameswaranVToneYLiLLiouHCGreeneMIet al. Development of Foxp3(+) regulatory t cells is driven by the c-Rel enhanceosome. Immunity. (2009) 31:932–40. doi: 10.1016/j.immuni.2009.10.006
33
PolanskyJKSchreiberLThelemannCLudwigLKrügerMBaumgrassRet al. Methylation matters: binding of Ets-1 to the demethylated Foxp3 gene contributes to the stabilization of Foxp3 expression in regulatory T cells. J Mol Med (Berl). (2010) 88:1029–40. doi: 10.1007/s00109-010-0642-1
34
ZhengYJosefowiczSChaudhryAPengXPForbushKRudenskyAY. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature. (2010) 463:808–12. doi: 10.1038/nature08750
35
ThorntonAMLuJKortyPEKimYCMartensCSunPDet al. Helios(+) and Helios(-) Treg subpopulations are phenotypically and functionally distinct and express dissimilar TCR repertoires. Eur J Immunol. (2019) 49:398–412. doi: 10.1002/eji.201847935
36
DrakeLYKitaH. IL-33: biological properties, functions, and roles in airway disease. Immunol Rev. (2017) 278:173–84. doi: 10.1111/imr.12552
37
SiedeJFröhlichADatsiAHegazyANVargaDVHolecskaVet al. IL-33 receptor-expressing regulatory T cells are highly activated, th2 biased and suppress CD4 T cell proliferation through IL-10 and TGFbeta release. PloS One. (2016) 11:e0161507. doi: 10.1371/journal.pone.0161507
38
HolgadoABraunHVan NuffelEDetrySSchuijsMJDeswarteKet al. IL-33trap is a novel IL-33-neutralizing biologic that inhibits allergic airway inflammation. J Allergy Clin Immunol. (2019) 144:204–15. doi: 10.1016/j.jaci.2019.02.028
39
SulimanHBSweeneyTEWithersCMPiantadosiCA. Co-regulation of nuclear respiratory factor-1 by NFkappaB and CREB links LPS-induced inflammation to mitochondrial biogenesis. J Cell Sci. (2010) 123:2565–75. doi: 10.1242/jcs.064089
40
MiragaiaRJGomesTChomkaAJardineLRiedelAHegazyANet al. Single-cell transcriptomics of regulatory T cells reveals trajectories of tissue adaptation. Immunity. (2019) 50:493–504 e497. doi: 10.1016/j.immuni.2019.01.001
41
KuhnRLöhlerJRennickDRajewskyKMüllerW. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. (1993) 75:263–74. doi: 10.1016/0092-8674(93)80068-P
42
SpencerSDDi MarcoFHooleyJPitts-MeekSBauerMRyanAMet al. The orphan receptor CRF2–4 is an essential subunit of the interleukin 10 receptor. J Exp Med. (1998) 187:571–8. doi: 10.1084/jem.187.4.571
43
SpathSRoanFPresnellSRHöllbacherBZieglerSF. Profiling of Tregs across tissues reveals plasticity in ST2 expression and hierarchies in tissue-specific phenotypes. iScience. (2022) 25:104998. doi: 10.1016/j.isci.2022.104998
Summary
Keywords
IL-33, ST2, Foxp3, IL-10, CREB, CREM
Citation
Hebbar Subramanyam S, Turyne Hriczko J, Schulz S, Look T, Goodarzi T, Clarner T, Scheld M, Kipp M, Verjans E, Böll S, Neullens C, Costa I, Li Z, Gan L, Denecke B, Schippers A, Floess S, Huehn J, Schmitt E, Bopp T, Wasmuth H, Winograd R, Beyaert R, Lambrecht B, Zenke M, Wagner N, Ohl K and Tenbrock K (2025) CREB regulates Foxp3+ST-2+ TREGS with enhanced IL-10 production. Front. Immunol. 16:1601008. doi: 10.3389/fimmu.2025.1601008
Received
27 March 2025
Accepted
04 June 2025
Published
24 July 2025
Corrected
29 August 2025
Volume
16 - 2025
Edited by
Deborah Yablonski, Technion Israel Institute of Technology, Israel
Reviewed by
Heth Roderick Turnquist, University of Pittsburgh, United States
Wayne Hancock, University of Pennsylvania, United States
Updates
Copyright
© 2025 Hebbar Subramanyam, Turyne Hriczko, Schulz, Look, Goodarzi, Clarner, Scheld, Kipp, Verjans, Böll, Neullens, Costa, Li, Gan, Denecke, Schippers, Floess, Huehn, Schmitt, Bopp, Wasmuth, Winograd, Beyaert, Lambrecht, Zenke, Wagner, Ohl and Tenbrock.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Klaus Tenbrock, ktenbrock@ukaachen.de
‡These authors have contributed equally to this work
†Present address: Martin Zenke, Department of Medicine IV, Hematology, Oncology, and Stem Cell Transplantation, Rheinisch-Westfälische Technische Hochschule Aachen University Hospital, Aachen, Germany Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Aachen, Germany
§Deceased
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.